Stroke Trial, Recruiting NCT05785156 Sponsor: Centre Hospitalier Universitaire, Amiens Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05785156
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 40 and 85 years old
  • People whose native language is French
  • People who are affiliated with the French Social Security system
  • People who have been assessed at a University Memory Clinic and have a mild or major memory or thinking disorder linked to Alzheimer's disease (based on specific medical assessment standards)
  • People diagnosed with a condition called Mild Cognitive Lewy body disease (based on McKeith criteria)
  • People diagnosed with a condition called Frontotemporal Lobar Degeneration (based on Rascovsky 2011 criteria)
  • People diagnosed with a condition called Basal Ganglia Disease (based on Armstrong's criteria)
  • People diagnosed with a condition called Progressive Supranuclear Palsy (based on Höglinger criteria)

Who may not be able to join:

  • People with an intellectual disability or who are under legal guardianship
  • People who have already been diagnosed with dementia before this trial
  • People who have or have had another brain condition not listed in the inclusion criteria
  • People who have had a severe head injury
  • People who have epilepsy that occurred before a stroke and still requires treatment
  • People who have Parkinson's disease or multiple sclerosis (or similar conditions)
  • People who have or have had a brain tumour, or who have received radiation therapy to the brain
  • People who have or have had schizophrenia or psychosis
  • People who have or have had a psychiatric condition that required a hospital stay of more than 2 days in a specialist psychiatric setting
  • People for whom an MRI scan is not medically safe (confirm with trial site)
  • People with another serious health condition where life expectancy is less than 1 year
  • People who drink more than 3 alcoholic drinks per day, or who have a history of alcohol withdrawal syndrome
  • People with a history of opiate or cocaine addiction, or opiate withdrawal syndrome
  • People with serious kidney problems (on dialysis or with very low kidney function)
  • People with serious liver problems (based on specific blood test results — confirm with trial site)
  • People with serious breathing problems that require oxygen therapy
  • People with serious heart failure that affects their ability to lie flat (needing more than 2 pillows to sleep)
  • People with ongoing disturbances to alertness or consciousness (confirm with trial site)
  • People with cancer that is affecting the nervous system (paraneoplastic syndrome)
  • People taking certain medications, including gold salts, D-Penicillamine, or other treatments known to affect thinking or memory
  • People under legal guardianship or curatorship, or who are restricted under public law
  • People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0322667813

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire, Amiens
Registry
ClinicalTrials.gov
Start date
16 July 2021
Est. completion
16 July 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Value of the speed of the action with the 'RT Componential Analysis of Action Speed' battery in all patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov